Cargando…
Evaluation of a Nanoparticle-Based Busulfan Immunoassay for Rapid Analysis on Routine Clinical Analyzers
Busulfan is an alkylating agent used in allogeneic hematopoietic stem cell transplantation for various malignant and nonmalignant disorders. Therapeutic drug monitoring of busulfan is common because busulfan exposure has been linked to veno-occlusive disease, disease relapse, and failed engraftment....
Autores principales: | Hilaire, Mary Rose, Gill, Regina V., Courtney, Jodi B., Baburina, Irina, Gardiner, JoAnn, Milone, Michael C., Shaw, Leslie M., Meng, Qing H., Salamone, Salvatore J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Therapeutic Drug Monitoring
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594508/ https://www.ncbi.nlm.nih.gov/pubmed/33814542 http://dx.doi.org/10.1097/FTD.0000000000000883 |
Ejemplares similares
-
Rapid Clozapine Blood Level Determination in a National Health Service Trust
por: Taylor, David, et al.
Publicado: (2023) -
Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy
por: Guidolin, Valeria, et al.
Publicado: (2023) -
Is there any difference between busulfan-cyclophosphamide and cyclophosphamide-busulfan in patients underwent allogeneic transplantation?
por: Bahçecioğlu, Ömer Faruk, et al.
Publicado: (2021) -
Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission
por: Saraceni, Francesco, et al.
Publicado: (2017) -
Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)